Resources

PATH’s Asset Tracker project provides information on the status of scale-up of key evidence-based interventions that improve maternal, newborn, and child health, and nutrition (MNCHN) outcomes, and save lives. The MNCHN Asset Tracker dashboards allow users to quickly and efficiently compare different indicators across or within countries. This guide is a how-to for reading, packaging, and presenting data from PATH’s MNCHN Asset Tracker to inform advocacy efforts.

This project fact sheet provides an overview of work that PATH will be leading to increase tuberculosis (TB) case notification and treatment completion, HIV case-finding, and COVID-19 vaccinations among people in underserved communities in the Democratic Republic of the Congo (DRC). With funding through Stop TB Partnership’s TB REACH Wave 10 grant program and in partnership with Humana People-to-People/DRC, Everwell Health Solutions, and the Programme National de Lutte contre la Tuberculosis, this project will test an integrated household screening model for TB, HIV, hypertension, and diabetes; co-create and pilot a revamped community directly-observed therapy, short-course (DOTS) adherence model; and introduce 99DOTS (digital TB adherence model) in Haut Katanga province.

PATH has been contributing to Nepal's health care transformation since 2014. PATH partners with governments and local organizations to strengthen health systems by addressing inequities in key health areas—vaccines and immunization, neglected tropical diseases, digital health, maternal, newborn, child health and nutrition, and disease surveillance.

PATH works to strengthen health equity through increased access to gender-responsive health services and innovations. Read this factsheet to learn more about our work in this area.

Medical devices are critical for detecting and treating many serious health conditions facing mothers and newborns, including anemia, pre-eclampsia, and neonatal respiratory distress. They also have expensive and complex training and maintenance needs and are thus challenging to manage effectively in low resource settings. However, there is a lack of systematic, cross-country, and cross-device data outlining these challenges and evaluating current device access.PATH led the Market Dynamics for Medical Devices (MD4MD) project to address this need, quantifying device availability and diagnosing key barriers to access for five priority countries and seven priority maternal, newborn, and child health (MNCH) devices. This report aims to summarize key findings from this research and outline an investment agenda for improving access to these critical devices.